Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles | Zendy

TsungHsien Lee | Zendy; C.-H. Liu | Zendy; C.-C. Huang | Zendy; Yi-Liang Wu | Zendy; Yu-Ting Shih | Zendy; HongNerng Ho | Zendy; YuShih Yang | Zendy; M.-S. Lee | Zendy

Open Access

Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles

Author(s) -

TsungHsien Lee,

C.-H. Liu,

C.-C. Huang,

Yi-Liang Wu,

Yu-Ting Shih,

HongNerng Ho,

YuShih Yang,

M.-S. Lee

Publication year - 2007

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dem254

Subject(s) - ovarian hyperstimulation syndrome , anti müllerian hormone , controlled ovarian hyperstimulation , medicine , odds ratio , gynecology , basal (medicine) , ovarian reserve , in vitro fertilisation , hormone , body mass index , pregnancy , endocrinology , biology , infertility , genetics , insulin

Anti-Müllerian hormone (AMH) is reported to be a reliable marker of the ovarian response to controlled ovarian stimulation (COS). The objective of this study is to determine whether the serum AMH level can predict ovarian hyperstimulation syndrome (OHSS) prior to selection of COS protocols.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research